Charles G. Eberhart

ORCID: 0000-0002-2910-9427
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Glioma Diagnosis and Treatment
  • Chromatin Remodeling and Cancer
  • Hedgehog Signaling Pathway Studies
  • Epigenetics and DNA Methylation
  • Ocular Oncology and Treatments
  • Cancer, Hypoxia, and Metabolism
  • MicroRNA in disease regulation
  • Cancer Mechanisms and Therapy
  • Cancer-related molecular mechanisms research
  • Neuroblastoma Research and Treatments
  • Cancer Cells and Metastasis
  • Cancer Genomics and Diagnostics
  • Circular RNAs in diseases
  • interferon and immune responses
  • Corneal Surgery and Treatments
  • Protein Degradation and Inhibitors
  • Corneal surgery and disorders
  • Cancer-related Molecular Pathways
  • Glaucoma and retinal disorders
  • Genomics and Chromatin Dynamics
  • RNA modifications and cancer
  • Developmental Biology and Gene Regulation
  • Hippo pathway signaling and YAP/TAZ
  • Microtubule and mitosis dynamics
  • Neurofibromatosis and Schwannoma Cases

Johns Hopkins Medicine
2016-2025

Johns Hopkins University
2016-2025

Sidney Kimmel Comprehensive Cancer Center
2015-2024

University of Baltimore
2013-2024

Johns Hopkins Hospital
2015-2024

National Institute of Neurological Disorders and Stroke
2024

Heidelberg University
2010-2023

Smith-Kettlewell Eye Research Institute
2023

Kennedy Krieger Institute
2014-2023

University of Michigan–Ann Arbor
2011-2022

Medulloblastoma, a small blue cell malignancy of the cerebellum, is major cause morbidity and mortality in pediatric oncology. Current mechanisms for clinical prognostication stratification include factors (age, presence metastases, extent resection) as well histological subgrouping (classic, desmoplastic, large cell/anaplastic histology). Transcriptional profiling studies medulloblastoma cohorts from several research groups around globe have suggested existence multiple distinct molecular...

10.1007/s00401-011-0922-z article EN cc-by-nc Acta Neuropathologica 2011-12-02

Recent genomic approaches have suggested the existence of multiple distinct subtypes medulloblastoma. We studied a large cohort medulloblastomas to determine how many subgroups disease exist, they differ, and extent overlap between subgroups.We determined gene expression profiles DNA copy number aberrations for 103 primary medulloblastomas. Bioinformatic tools were used class discovery medulloblastoma based on most informative genes in data set. Immunohistochemistry subgroup-specific...

10.1200/jco.2009.27.4324 article EN Journal of Clinical Oncology 2010-09-08
Florence M.G. Cavalli Marc Remke Ladislav Rampášek John Peacock David Shih and 90 more Betty Luu Livia Garzia Jonathon Torchia Carolina Nör A. Sorana Morrissy Sameer Agnihotri Yuan Thompson Claudia M. Kuzan-Fischer Hamza Farooq Keren Isaev Craig Daniels Byung-Kyu Cho Seung-Ki Kim Kyu‐Chang Wang Ji Yeoun Lee Wiesława Grajkowska Marta Perek‐Polnik Alexandre Vasiljevic Cécile Faure‐Conter Anne Jouvet Caterina Giannini Amulya A. Nageswara Rao Kay Ka Wai Li Ho‐Keung Ng Charles G. Eberhart Ian F. Pollack Ronald L. Hamilton G. Yancey Gillespie James M. Olson Sarah Leary William A. Weiss Bolesław Lach Lola B. Chambless Reid C. Thompson Michael K. Cooper Rajeev Vibhakar Péter Hauser Marie‐Lise C. van Veelen Johan M. Kros Pim J. French Young Seob Shin Toshihiro Kumabe Enrique López‐Aguilar Karel Zitterbart Jaroslav Štěrba Gaetano Finocchiaro Maura Massimino Erwin G. Van Meir Satoru Osuka Tomoko Shofuda Álmos Klekner Massimo Zollo Jeffrey R. Leonard Joshua B. Rubin Nada Jabado Steffen Albrecht Jaume Mora Timothy Van Meter Shin Jung Andrew S. Moore Andrew R. Hallahan Jennifer A. Chan Daniela Pretti da Cunha Tirapelli Carlos Gilberto Carlotti Maryam Fouladi José Pimentel Cláudia C. Faria Ali G. Saad Luca Massimi Linda M. Liau Helen Wheeler Hideo Nakamura Samer K. Elbabaa Mario Pérezpeña-Díazconti Fernando Chico Ponce de León Shenandoah Robinson Michal Zápotocký Álvaro Lassaletta Annie Huang Cynthia Hawkins Uri Tabori Éric Bouffet Ute Bartels Peter B. Dirks James T. Rutka Gary D. Bader Jüri Reimand Anna Goldenberg Vijay Ramaswamy Michael D. Taylor

10.1016/j.ccell.2017.05.005 article EN publisher-specific-oa Cancer Cell 2017-06-01

The proteins encoded by ATRX and DAXX participate in chromatin remodeling at telomeres other genomic sites. Because inactivating mutations of these genes are common human pancreatic neuroendocrine tumors (PanNETs), we examined the telomere status tumors. We found that 61% PanNETs displayed abnormal characteristic a telomerase-independent maintenance mechanism termed ALT (alternative lengthening telomeres). All exhibiting had or loss nuclear protein. also correlate with central nervous...

10.1126/science.1207313 article EN Science 2011-07-01
Paul A. Northcott David Shih John Peacock Livia Garzia A. Sorana Morrissy and 95 more Thomas Zichner Adrian M. Stütz Andrey Korshunov Jüri Reimand Steven E. Schumacher Rameen Beroukhim David W. Ellison Christian R. Marshall Anath C. Lionel Stephen C. Mack Adrian M. Dubuc Yuan Yao Vijay Ramaswamy Betty Luu Adi Rolider Florence M.G. Cavalli Xin Wang Marc Remke Xiaochong Wu Readman Chiu Andy Chu Eric Chuah Richard Corbett Gemma R Hoad Shaun D. Jackman Yisu Li Allan Lo Karen Mungall Ka Ming Nip Jenny Q. Qian Anthony Raymond Nina Thiessen Richard Varhol İnanç Birol Richard A. Moore Andrew J. Mungall Robert A. Holt Daisuke Kawauchi Martine F. Roussel Marcel Kool David Jones Hendrick Witt Africa Fernández-L Anna Marie Kenney Robert J. Wechsler‐Reya Peter B. Dirks Tzvi Aviv Wiesława Grajkowska Marta Perek‐Polnik Christine Haberler Olivier Delattre Stéphanie Reynaud François Doz Sarah S. Pernet-Fattet Byung-Kyu Cho Seung-Ki Kim Kyu‐Chang Wang Wolfram Scheurlen Charles G. Eberhart Michelle Fèvre‐Montange Anne Jouvet Ian F. Pollack Xing Fan Karin M. Muraszko G. Yancey Gillespie Concezio Di Rocco Luca Massimi Erna Michiels Nanne K. Kloosterhof Pim J. French Johan M. Kros James M. Olson Richard G. Ellenbogen Karel Zitterbart Leoš Křen Reid C. Thompson Michael K. Cooper Bolesław Lach Roger E. McLendon Darell D. Bigner Adam M. Fontebasso Steffen Albrecht Nada Jabado Janet C. Lindsey Simon Bailey Nalin Gupta William A. Weiss László Bognár Álmos Klekner Timothy Van Meter Toshihiro Kumabe Teiji Tominaga Samer K. Elbabaa Jeffrey R. Leonard Joshua B. Rubin

Medulloblastoma, the most common malignant paediatric brain tumour, is currently treated with nonspecific cytotoxic therapies including surgery, whole-brain radiation, and aggressive chemotherapy. As medulloblastoma exhibits marked intertumoural heterogeneity, at least four distinct molecular variants, previous attempts to identify targets for therapy have been underpowered because of small samples sizes. Here we report somatic copy number aberrations (SCNAs) in 1,087 unique...

10.1038/nature11327 article EN cc-by-nc-sa Nature 2012-07-24

Constitutive Hedgehog (Hh) pathway activity is associated with initiation of neoplasia, but its role in the continued growth established tumors unclear. Here, we investigate therapeutic efficacy Hh antagonist cyclopamine preclinical models medulloblastoma, most common malignant brain tumor children. Cyclopamine treatment murine medulloblastoma cells blocked proliferation vitro and induced changes gene expression consistent neuronal differentiation loss stem cell–like character. This compound...

10.1126/science.1073733 article EN Science 2002-08-29

Medulloblastomas are heterogeneous tumors that collectively represent the most common malignant brain tumor in children. To understand molecular characteristics underlying their heterogeneity and to identify whether such risk factors for patients with this disease, we performed an integrated genomic analysis of a large series primary tumors.We profiled mRNA transcriptome 194 medulloblastomas high-density single nucleotide polymorphism array miRNA on 115 98 these, respectively. Non-negative...

10.1200/jco.2010.28.5148 article EN Journal of Clinical Oncology 2010-11-23

Cancer stem cells (CSCs) are thought to be critical for the engraftment and long-term growth of many tumors, including glioblastoma (GBM). The at least partially spared by traditional chemotherapies radiation therapies, finding new treatments that can target CSCs may improving patient survival. It has been shown NOTCH signaling pathway regulates normal in brain, GBMs contain stem-like with higher activity. We therefore used low-passage established GBM-derived neurosphere cultures examine...

10.1002/stem.254 article EN Stem Cells 2009-11-10

Abstract The Notch signaling pathway is required in both nonneoplastic neural stem cells and embryonal brain tumors, such as medulloblastoma, which are derived from cells. We investigated the effects of inhibition on medulloblastoma growth using pharmacologic inhibitors γ-secretase. blockade suppressed expression target Hes1 caused cell cycle exit, apoptosis, differentiation lines. Interestingly, viable populations better-differentiated continued to grow when activation was inhibited but...

10.1158/0008-5472.can-06-0858 article EN Cancer Research 2006-08-01

Nanoparticles densely coated with poly(ethylene glycol) rapidly penetrate within mouse, rat, and human brain parenchyma.

10.1126/scitranslmed.3003594 article EN Science Translational Medicine 2012-08-29

Abstract Brain tumors can arise following deregulation of signaling pathways normally activated during brain development and may derive from neural stem cells. Given the requirement for Hedgehog in non-neoplastic cells, we investigated whether blockade could target stem-like population glioblastoma multiforme (GBM). We found that Gli1, a key pathway target, was highly expressed 5 19 primary GBM 4 7 cell lines. Shh ligand some tumors, GBM-derived neurospheres, suggesting potential mechanism...

10.1634/stemcells.2007-0166 article EN Stem Cells 2007-07-12

The Notch family of proteins plays an integral role in determining cell fates, such as proliferation, differentiation, and apoptosis. We show that Notch-1 its ligands, Delta-like-1 Jagged-1, are overexpressed many glioma lines primary human gliomas. Immunohistochemistry a tissue array shows the presence nucleus intracellular domain, indicating activation situ. Down-regulation Notch-1, Delta-like-1, or Jagged-1 by RNA interference induces apoptosis inhibits proliferation multiple lines. In...

10.1158/0008-5472.can-04-1890 article EN Cancer Research 2005-03-15

Major discoveries in the biology of nervous system tumors have raised question how non-histological data such as molecular information can be incorporated into next World Health Organization (WHO) classification central tumors. To address this question, a meeting neuropathologists with expertise diagnosis was held Haarlem, Netherlands, under sponsorship International Society Neuropathology (ISN). Prior to meeting, participants solicited input from clinical colleagues diverse...

10.1111/bpa.12171 article EN cc-by Brain Pathology 2014-07-03

cIMPACT-NOW (the Consortium to Inform Molecular and Practical Approaches CNS Tumor Taxonomy) was established evaluate make practical recommendations on recent advances in the field of tumor classification, particularly light rapid progress molecular insights into these neoplasms. For Round 2 its deliberations, Working Committee 3 reconstituted convened Utrecht, The Netherlands, for a meeting designed review putative new types advance any future World Health Organization classification. In...

10.1111/bpa.12832 article EN Brain Pathology 2020-04-19

Reports detailing the prognostic impact of TP53 mutations in medulloblastoma offer conflicting conclusions. We resolve this issue through inclusion molecular subgroup profiles.We determined affiliation, mutation status, and clinical outcome a discovery cohort 397 medulloblastomas. subsequently validated our results on an independent 156 medulloblastomas.TP53 are enriched wingless (WNT; 16%) sonic hedgehog (SHH; 21%) medulloblastomas virtually absent subgroups 3 4 tumors (P < .001). Patients...

10.1200/jco.2012.48.5052 article EN Journal of Clinical Oncology 2013-07-09

Abstract The role of Notch signaling in tumorigenesis can vary; Notch1 acts as an oncogene some neoplasms, and a tumor suppressor others. Here, we show that different receptors have opposite effects single type. Expression truncated, constitutively active or Notch2 embryonal brain cell lines caused antagonistic on growth. Cell proliferation, soft agar colony formation, xenograft growth were all promoted by inhibited Notch1. We also found receptor transcripts are highly expressed progenitor...

10.1158/0008-5472.can-04-1446 article EN Cancer Research 2004-11-01

The diagnosis of medulloblastoma likely encompasses several distinct entities, with recent evidence for the existence at least four unique molecular subgroups that exhibit genetic, transcriptional, demographic, and clinical features. Assignment subgroup through routine profiling high-quality RNA on expression microarrays is impractical in setting. planning execution trials stratify by subgroup, or which are targeted to a specific requires technologies can be economically, rapidly, reliably,...

10.1007/s00401-011-0899-7 article EN cc-by-nc Acta Neuropathologica 2011-11-05
Coming Soon ...